A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 981,596 shares of ABBV stock, worth $167 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
981,596
Previous 997,199 1.56%
Holding current value
$167 Million
Previous $171 Million 13.33%
% of portfolio
0.6%
Previous 0.55%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $2.56 Million - $3.11 Million
-15,603 Reduced 1.56%
981,596 $194 Million
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $2.21 Million - $2.58 Million
-14,283 Reduced 1.41%
997,199 $171 Million
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $1.42 Million - $1.62 Million
-8,884 Reduced 0.87%
1,011,482 $184 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $1.78 Million - $2.01 Million
-12,949 Reduced 1.25%
1,020,366 $158 Million
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $3.24 Million - $3.75 Million
-24,230 Reduced 2.29%
1,033,315 $154 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $1.93 Million - $2.4 Million
-14,580 Reduced 1.36%
1,057,545 $142 Million
Q1 2023

May 17, 2023

BUY
$144.61 - $166.54 $150 Million - $173 Million
1,040,498 Added 3289.9%
1,072,125 $171 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $149 Million - $172 Million
-1,030,187 Reduced 97.02%
31,627 $5.04 Billion
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $8.54 Million - $10.2 Million
-61,737 Reduced 5.49%
1,061,814 $172 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $1.67 Million - $1.91 Million
12,408 Added 1.12%
1,123,551 $151 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $587,499 - $746,904
4,269 Added 0.39%
1,111,143 $170 Million
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $152,436 - $189,131
1,155 Added 0.1%
1,106,874 $179 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $2.39 Million - $3.02 Million
-22,219 Reduced 1.97%
1,105,719 $150 Million
Q3 2021

Oct 20, 2021

SELL
$106.4 - $120.78 $4.55 Million - $5.16 Million
-42,718 Reduced 3.65%
1,127,938 $122 Million
Q2 2021

Jul 20, 2021

SELL
$105.21 - $117.21 $6.46 Million - $7.19 Million
-61,383 Reduced 4.98%
1,170,656 $132 Million
Q1 2021

Apr 22, 2021

SELL
$102.3 - $112.62 $6.92 Million - $7.62 Million
-67,632 Reduced 5.2%
1,232,039 $133 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $4.83 Million - $6.52 Million
-59,976 Reduced 4.41%
1,299,671 $139 Million
Q3 2020

Nov 06, 2020

SELL
$85.91 - $100.83 $11.8 Million - $13.8 Million
-136,895 Reduced 9.15%
1,359,647 $119 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $12.2 Million - $16.3 Million
166,521 Added 12.52%
1,496,542 $147 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $1.14 Million - $1.73 Million
17,736 Added 1.35%
1,330,021 $101 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $258,802 - $323,817
-3,588 Reduced 0.27%
1,312,285 $116 Million
Q3 2019

Nov 20, 2019

SELL
$62.98 - $75.72 $258,029 - $310,224
-4,097 Reduced 0.31%
1,315,873 $99.6 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $154,526 - $197,520
-2,352 Reduced 0.18%
1,319,970 $96 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $755,123 - $888,743
-9,789 Reduced 0.73%
1,322,322 $105 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $3.05 Million - $3.76 Million
-39,195 Reduced 2.86%
1,332,111 $123 Million
Q3 2018

Oct 23, 2018

SELL
$88.91 - $98.84 $2.87 Million - $3.19 Million
-32,271 Reduced 2.3%
1,371,306 $130 Million
Q2 2018

Aug 02, 2018

SELL
$89.78 - $106.23 $6.24 Million - $7.39 Million
-69,543 Reduced 4.72%
1,403,577 $130 Million
Q1 2018

Apr 10, 2018

SELL
$92.01 - $123.21 $2.65 Million - $3.55 Million
-28,773 Reduced 1.92%
1,473,120 $139 Million
Q4 2017

Jan 22, 2018

SELL
$89.56 - $98.21 $1.05 Million - $1.15 Million
-11,675 Reduced 0.77%
1,501,893 $145 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $106 Million - $135 Million
1,513,568
1,513,568 $134 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.